Literature DB >> 27324050

Hepatitis E virus RNA-dependent RNA polymerase: RNA template specificities, recruitment and synthesis.

Shakuntala Mahilkar1, Mandar S Paingankar2, Kavita S Lole1.   

Abstract

Hepatitis E virus (HEV) is a positive-sense RNA virus and member of the genus Orthohepevirus in the family Hepeviridae. Although HEV RNA-dependent RNA polymerase (HEV-RdRp) plays an important role in the HEV life cycle, its template specificities are not completely understood. We expressed HEV-RdRp protein with His-tag in a bacterial system and analysed template specificities using different putative cis-regulatory elements in the HEV genome. The enzyme showed highest affinity for the 3' non-coding region (NCR), then for the 5'NCR and least for the putative subgenomic promoter (SgP). The enzyme could co-bind to 3'NCR and putative SgP templates together, as evident from the supershift in binding assay, indicating presence of different binding sites for these elements. Proteomic analysis revealed that the RNA elements share two common peptides for binding, while a third peptide, which is highly conserved across different HEV genotypes, is specific for 3'NCR. We propose that, during the early phases of replication, as negative sense antigenome copies accumulate at the replication site, they probably initiate promoter swapping from 3'NCR to SgP, to favour synthesis of subgenomic RNA and to prevent synthesis of genomic RNA. The conserved site for 3'NCR binding could be potential antiviral target and needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27324050     DOI: 10.1099/jgv.0.000528

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 2.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

3.  Roles of the genomic sequence surrounding the stem-loop structure in the junction region including the 3' terminus of open reading frame 1 in hepatitis E virus replication.

Authors:  Dianjun Cao; Yan-Yan Ni; Michelle Walker; Yao-Wei Huang; Xiang-Jin Meng
Journal:  J Med Virol       Date:  2018-05-25       Impact factor: 2.327

4.  Identification of the Intragenomic Promoter Controlling Hepatitis E Virus Subgenomic RNA Transcription.

Authors:  Qiang Ding; Ila Nimgaonkar; Nicholas F Archer; Yaron Bram; Brigitte Heller; Robert E Schwartz; Alexander Ploss
Journal:  MBio       Date:  2018-05-08       Impact factor: 7.867

Review 5.  Life cycle and morphogenesis of the hepatitis E virus.

Authors:  Kiyoshi Himmelsbach; Daniela Bender; Eberhard Hildt
Journal:  Emerg Microbes Infect       Date:  2018-11-29       Impact factor: 7.163

6.  Analysis of Hepatitis E virus (HEV) X-domain structural model.

Authors:  Thakur Vikram; Pradeep Kumar
Journal:  Bioinformation       Date:  2018-07-31

Review 7.  Hepatitis E Virus Replication.

Authors:  Robert LeDesma; Ila Nimgaonkar; Alexander Ploss
Journal:  Viruses       Date:  2019-08-06       Impact factor: 5.048

8.  Protein Interactions Network of Hepatitis E Virus RNA and Polymerase With Host Proteins.

Authors:  Gayatri D Kanade; Kunal D Pingale; Yogesh A Karpe
Journal:  Front Microbiol       Date:  2019-11-01       Impact factor: 5.640

Review 9.  Advances in Hepatitis E Virus Biology and Pathogenesis.

Authors:  Shaoli Lin; Yan-Jin Zhang
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

10.  Molecular Analysis and Modeling of Hepatitis E Virus Helicase and Identification of Novel Inhibitors by Virtual Screening.

Authors:  Mohammad K Parvez; Naidu Subbarao
Journal:  Biomed Res Int       Date:  2018-08-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.